Search research articles
Contact Us
Filters
Showing results (71-80 of 99) with videos related to
Page
of 10
Sort By:
NPJ Schizophrenia
|
August 3, 2019
Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
Kate Merritt, Rocio Perez-Iglesias, Kyra-Verena Sendt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
Gemma Modinos, Anja Richter, Alice Egerton, et al.
Schizophrenia Research
|
June 28, 2016
Adversity in childhood linked to elevated striatal dopamine function in adulthood
Alice Egerton, Lucia R Valmaggia, Oliver D Howes, et al.
Frontiers in Psychiatry
|
March 27, 2023
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
Dominic Oliver, Cathy Davies, Fernando Zelaya, et al.
Schizophrenia Research
|
September 1, 2023
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia
Kira Griffiths, Sophie E Smart, Gareth J Barker, et al.
BMJ Open
|
November 26, 2021
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
Edward Millgate, Eugenia Kravariti, Alice Egerton, et al.
Brain, Behavior, and Immunity
|
October 13, 2023
Changes in immunoglobulin levels during clozapine treatment in schizophrenia
Kira Griffiths, Maria Ruiz Mellado, Raymond Chung, et al.
Biological Psychiatry
|
February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis
Thomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis
Alice Egerton, James M Stone, Christopher A Chaddock, et al.
Schizophrenia Bulletin
|
January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
Grant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 99) with videos related to
Sort By:
Page
of 10
NPJ Schizophrenia
|
August 3, 2019
Remission from antipsychotic treatment in first episode psychosis related to longitudinal changes in brain glutamate
Kate Merritt, Rocio Perez-Iglesias, Kyra-Verena Sendt, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
May 4, 2021
Interactions between hippocampal activity and striatal dopamine in people at clinical high risk for psychosis: relationship to adverse outcomes
Gemma Modinos, Anja Richter, Alice Egerton, et al.
Schizophrenia Research
|
June 28, 2016
Adversity in childhood linked to elevated striatal dopamine function in adulthood
Alice Egerton, Lucia R Valmaggia, Oliver D Howes, et al.
Frontiers in Psychiatry
|
March 27, 2023
Parsing neurobiological heterogeneity of the clinical high-risk state for psychosis: A pseudo-continuous arterial spin labelling study
Dominic Oliver, Cathy Davies, Fernando Zelaya, et al.
Schizophrenia Research
|
September 1, 2023
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia
Kira Griffiths, Sophie E Smart, Gareth J Barker, et al.
BMJ Open
|
November 26, 2021
Cross-sectional study comparing cognitive function in treatment responsive versus treatment non-responsive schizophrenia: evidence from the STRATA study
Edward Millgate, Eugenia Kravariti, Alice Egerton, et al.
Brain, Behavior, and Immunity
|
October 13, 2023
Changes in immunoglobulin levels during clozapine treatment in schizophrenia
Kira Griffiths, Maria Ruiz Mellado, Raymond Chung, et al.
Biological Psychiatry
|
February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode Psychosis
Thomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis
Alice Egerton, James M Stone, Christopher A Chaddock, et al.
Schizophrenia Bulletin
|
January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant Schizophrenia
Grant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Page
of 10